Earn Up to 2 Hours of CME!

Pre-Registration is required.

Registration Fee: $25.00

Program Description

This continuing medical education conference is designed to provide healthcare professionals with the latest evidence and clinical perspectives on the use of factor Xla inhibitors in stroke prevention. Through expert-led presentations and interactive sessions, participants will explore the rationale for targeting factor Xla, review recent phase 3 clinical trial designs and outcomes, and compare emerging therapies with established antithrombotic strategies. The program will also address current challenges and unmet needs in secondary stroke prevention, fostering a deeper understanding of novel therapeutic approaches. Attendees will leave equipped with practical knowledge and increased confidence to integrate new and emerging therapies into the management of patients at risk for schemic stroke and transient ischemic attacks.